Literature DB >> 17217977

Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Christian D S Nelson1, Laura M Palermo, Susan L Hafenstein, Colin R Parrish.   

Abstract

Antibody binding and neutralization are major host defenses against viruses, yet the mechanisms are often not well understood. Eight monoclonal antibodies and their Fab fragments were tested for neutralization of canine parvovirus and feline panleukopenia virus. All IgGs neutralized >85% of virus infectivity. Two Fabs neutralized when present at 5 nM, while the others gave little or no neutralization even at 20-100 nM. The antibodies bind two antigenic sites on the capsids which overlap the binding site of the host transferrin receptor (TfR). There was no specific correlation between Fab binding affinity and neutralization. All Fabs reduced capsid binding of virus to purified feline TfR in vitro, but the highly neutralizing Fabs were more efficient competitors. All partially prevented binding and uptake of capsids by feline TfR on cells. The virus appears adapted to allow some infectivity in the presence of at least low levels of antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217977      PMCID: PMC1991280          DOI: 10.1016/j.virol.2006.11.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  90 in total

Review 1.  Picornavirus-receptor interactions.

Authors:  Michael G Rossmann; Yongning He; Richard J Kuhn
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

Review 2.  Antibodies, viruses and vaccines.

Authors:  Dennis R Burton
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

3.  Pathogenic potential of canine parvovirus types 2a and 2c in domestic cats.

Authors:  K Nakamura; M Sakamoto; Y Ikeda; E Sato; K Kawakami; T Miyazawa; Y Tohya; E Takahashi; T Mikami; M Mochizuki
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

4.  Genomic typing of canine parvovirus circulating in the State of Rio de Janeiro, Brazil from 1995 to 2001 using polymerase chain reaction assay.

Authors:  A P Costa; J P G Leite; N V Labarthe; R C N Cubel Garcia
Journal:  Vet Res Commun       Date:  2005-11       Impact factor: 2.459

5.  Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus.

Authors:  H Sheshberadaran; E Norrby; K W Rammohan
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Canine parvovirus capsid structure, analyzed at 2.9 A resolution.

Authors:  Q Xie; M S Chapman
Journal:  J Mol Biol       Date:  1996-12-06       Impact factor: 5.469

7.  Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence.

Authors:  J I Casal; J P Langeveld; E Cortés; W W Schaaper; E van Dijk; C Vela; S Kamstrup; R H Meloen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  The structure of human parvovirus B19.

Authors:  Bärbel Kaufmann; Alan A Simpson; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

9.  Evolution of canine parvovirus involved loss and gain of feline host range.

Authors:  U Truyen; J F Evermann; E Vieler; C R Parrish
Journal:  Virology       Date:  1996-01-15       Impact factor: 3.616

10.  B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.

Authors:  J P Langeveld; J I Casal; C Vela; K Dalsgaard; S H Smale; W C Puijk; R H Meloen
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more
  31 in total

1.  Family level phylogenies reveal modes of macroevolution in RNA viruses.

Authors:  Andrew Kitchen; Laura A Shackelton; Edward C Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

2.  Canine parvovirus type 2b is the most prevalent genomic variant strain found in parvovirus antigen positive diarrheic dog feces samples across Canada.

Authors:  Carl A Gagnon; Véronique Allard; Guillaume Cloutier
Journal:  Can Vet J       Date:  2016-01       Impact factor: 1.008

3.  Detecting small changes and additional peptides in the canine parvovirus capsid structure.

Authors:  Christian D S Nelson; Eveliina Minkkinen; Magnus Bergkvist; Karin Hoelzer; Mathew Fisher; Brian Bothner; Colin R Parrish
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

4.  Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.

Authors:  A Corden; B Handelman; H Yin; A Cotrim; I Alevizos; J A Chiorini
Journal:  Gene Ther       Date:  2017-02-02       Impact factor: 5.250

5.  Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007.

Authors:  Sanjay Kapil; Emily Cooper; Cathy Lamm; Brandy Murray; Grant Rezabek; Larry Johnston; Gregory Campbell; Bill Johnson
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

6.  The genetic evolution of canine parvovirus - A new perspective.

Authors:  Pei Zhou; Weijie Zeng; Xin Zhang; Shoujun Li
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

7.  Near-Atomic Resolution Structure of a Highly Neutralizing Fab Bound to Canine Parvovirus.

Authors:  Lindsey J Organtini; Hyunwook Lee; Sho Iketani; Kai Huang; Robert E Ashley; Alexander M Makhov; James F Conway; Colin R Parrish; Susan Hafenstein
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

8.  Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

Authors:  John T Bates; Christopher J Keefer; Thomas J Utley; Bruno E Correia; William R Schief; James E Crowe
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

9.  Structural comparison of different antibodies interacting with parvovirus capsids.

Authors:  Susan Hafenstein; Valorie D Bowman; Tao Sun; Christian D S Nelson; Laura M Palermo; Paul R Chipman; Anthony J Battisti; Colin R Parrish; Michael G Rossmann
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

10.  Complex and Dynamic Interactions between Parvovirus Capsids, Transferrin Receptors, and Antibodies Control Cell Infection and Host Range.

Authors:  Heather M Callaway; Kathrin Welsch; Wendy Weichert; Andrew B Allison; Susan L Hafenstein; Kai Huang; Sho Iketani; Colin R Parrish
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.